InsidersTradesSigma
휴메딕스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 휴메딕스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 휴메딕스 has logged 2 reports. Market capitalisation: €269.8bn. The latest transaction was disclosed on 27 April 2026 (Purchase). Among the most active insiders: 휴온스글로벌. The full history is free.
2
Insider Decl.
n/a
Thresholds
€115,434
2 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 506 of 28,134 companies
84.5
score / 100
Value92
Quality77
FCF yld13%
Earn yld18%
EV/EBITDA4.0x
ROE7.3%
Gross mgn47%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 April 2026
About 휴메딕스
Humedics is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development of innovative medical products.